The following is an excerpt.
Myriad Genetics Inc. (MYGN)’s Australian court victory recognizing its ownership of patents for genes linked to cancer risks will be appealed by a group representing cancer patients, a law firmsaid.
Cancer Voices Australia and Yvonne D’Arcy, a Brisbane resident diagnosed with breast cancer, sued in 2010 to stop Myriad and Genetic Technologies Ltd. (GTG) from patenting an isolated DNA associated with an increased risk of breast and ovarian cancers, according to Maurice Blackburn Lawyers. The firm said it has filed the appeal in the Federal Court of Australia today
Related on the SLP
View the original article here: Myriad Genetics Win on Gene Patent Ownership Is Appealed
